Medical Progress Today
mpt home | sign up

Volume 4, Number 15
April 27, 2007


PRINTER FRIENDLY

News

Prostate cancer test's accuracy cited
Los Angeles Times, 4-26-07

Editor's Notes:

The L.A. Times reports on the potential discovery of a new biomarker for prostate cancer that may be significantly more accurate than the current PSA (prostate specific antigen) test, which has a very high rate of false positives. Each false positive test may expose men to a painful and unnecessary prostate biopsy.
Continue reading . . .

Most doctors get money, gifts from industry; Research questions sellers' influence
USA Today, 4-26-07

Editor's Notes:

USA Today reports on a study this week in the New England Journal of Medicine that finds that most doctors receive "gifts" from industry (pharmaceutical and device manufacturers), including receiving free trinkets, lunch, or consulting fees.
Continue reading . . .

Free NHS a mirage, say doctors
Telegraph, 4-25-07

Editor's Notes:

A new physician–sponsored study in the United Kingdom finds many patients there paying extra for supplemental health care services provided by private insurance. This insurance, called "top–up" coverage, is meant to make up for shortfalls and long waiting times in the UK's "free" (Read: tax-payer financed) National Health Service.
Continue reading . . .

Wal-Mart to open 400 in-store clinics
Reuters News, 4-24-07

Editor's Notes:

While Washington dithers on health care reform, the market is finding new ways to make health care more accessible and affordable for every day consumers. In addition to launching a ground breaking program of $4 generic prescriptions, Wal–Mart announced this week that it is adding hundreds more low–cost convenient care clinics to its stores.
Continue reading . . .

Anemia drug trial's tardiness at issue
Los Angeles Times, 4-24-07

Editor's Notes:

As questions swirl around the safety of Amgen's anemia drug, Aranesp, in some patient sub–populations, observers are asking a bigger question: Why aren't some of these safety signals being caught sooner?
Continue reading . . .

Thai Showdown Spotlights Threat to Drug Patents
Wall Street Journal, 4-24-07

Editor's Notes:

Ever since Thailand announced that it was breaking the patent on Abbott's AIDS drug Kaletra, the company has struggled to defend its intellectual property rights and win the battle of public opinion. It appears to be losing on both fronts.
Continue reading . . .

Commentary

Financial Cure Overdue: America’s ailing Medicare, Social Security Programs
The Atlanta Journal–Constitution, 4-26-07

The editors at the Journal-Constitution ask when Congress will get serious about reforming Medicare and Social Security. Their answer: Don't hold your breath.
Continue reading . . .

Researcher makes his mark— By establishing goals, Robert Ruffolo helped Wyeth step up its R&D game
The Star-Ledger, 4-25-07

This is a short, but very interesting, interview with Robert Ruffolo, head of research at Wyeth Pharmaceuticals. Ruffolo discusses Wyeth's metric driven research strategy and why the risks of drugs have to be measured against their benefits.
Continue reading . . .

The Angel is in the Details
Henry I. Miller, TCS Daily, 4-25-07

Miller argues that misunderstandings and downright ignorance surrounding biotechnology are critically slowing the dissemination of badly needed new technologies.
Continue reading . . .

Responsible Medicine
Tom Coburn, Washington Times, 4-24-07

Coburn defends federal legislation that gives pharmaceutical companies a powerful financial incentive to study their medicines in children, where such research is often badly lacking.
Continue reading . . .

Risky Drug Business
Richard A. Epstein, Wall Street Journal, 4-24-07

Epstein, a law professor at the University of Chicago, analyzes new Congressional legislation that reauthorizes the Prescription Drug User Fee Act.
Continue reading . . .

Black Box Backfire
Gilbert L. Ross, M.D., Wall Street Journal, 4-21-07

Ross examines how the FDA's 2004 warnings over potential suicide risks for antidepressants in children may have scared some parents away from these drugs, leading to a surge in teen suicides.
Continue reading . . .


Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

In this week's issue:

NEWS

Prostate cancer test's accuracy cited
Most doctors get money, gifts from industry; Research questions sellers' influence
Free NHS a mirage, say doctors
Wal-Mart to open 400 in-store clinics
Anemia drug trial's tardiness at issue
Thai Showdown Spotlights Threat to Drug Patents

COMMENTARY

Financial Cure Overdue: America’s ailing Medicare, Social Security Programs
Researcher makes his mark— By establishing goals, Robert Ruffolo helped Wyeth step up its R&D game
The Angel is in the Details
Responsible Medicine
Risky Drug Business
Black Box Backfire

COMING SOON!!

New book by Regina Herzlinger: Who Killed Health Care: America's $1.5 Trillion Problem - and the Consumer-Driven Cure (McGraw-Hill, June 2007)

Advanced copies available now at Amazon

Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org